Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Vanguard Index FdsTotal Stock Market | 1,038,550 | 1,038,550 | 0 | $285.44M | $315.65M | 22.28% | +$30.21M |
| Brookfield CorporationCL A(BN) | 2,330,830 | 2,330,830 | 0 | $122.16M | $144.16M | 10.18% | +$22.00M |
| Asml Holding N VN Y REGISTRY SHS N Y REGISTRY SHS | 165,836 | 165,836 | 0 | $109.89M | $132.90M | 9.38% | +$23.01M |
| Salesforce, Inc.(CRM) | 272,801 | 330,187 | +57,386 | $73.21M | $90.04M | 6.36% | +$16.83M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 1,500,000 | 1,500,055 | +55 | $67.58M | $76.34M | 5.39% | +$8.76M |
| Edgewise Therapeutics, Inc.(EWTX) | 5,350,000 | 5,350,000 | 0 | $117.70M | $70.14M | 4.95% | -$47.56M |
| Insmed Incorporated(INSM) | 724,666 | 680,000 | -44,666 | $55.28M | $68.44M | 4.83% | +$13.15M |
| Recursion Pharmaceuticals, Inc.CL A(RXRX) | 9,665,128 | 9,665,128 | 0 | $51.13M | $48.91M | 3.45% | -$2.22M |
| Crinetics Pharmaceuticals In | 1,275,000 | 1,550,000 | +275,000 | $42.76M | $44.58M | 3.15% | +$1.81M |
| Alibaba Group Holding LimitedADS(BABA) | 372,327 | 372,327 | 0 | $49.23M | $42.23M | 2.98% | -$7.01M |
| ArriVent BioPharma, Inc.(AVBP) | 1,872,142 | 1,872,142 | 0 | $34.62M | $40.76M | 2.88% | +$6.14M |
| Merus N V | 789,129 | 750,000 | -39,129 | $33.21M | $39.45M | 2.78% | +$6.24M |
| BioMarin Pharmaceutical Inc.(BMRN) | 490,000 | 660,000 | +170,000 | $34.64M | $36.28M | 2.56% | +$1.64M |
| Blueprint Medicines Corp | 228,804 | 264,956 | +36,152 | $20.25M | $33.96M | 2.40% | +$13.71M |
| Viridian Therapeutics, Inc.(VRDN) | 2,250,300 | 2,380,000 | +129,700 | $30.33M | $33.27M | 2.35% | +$2.94M |
| Pharvaris N V COM | 1,725,000 | 1,725,000 | 0 | $27.08M | $30.36M | 2.14% | +$3.28M |
| Vaxcyte, Inc.(PCVX) | 915,000 | 916,160 | +1,160 | $34.55M | $29.78M | 2.10% | -$4.77M |
| Celldex Therapeutics, Inc.(CLDX) | 1,200,000 | 1,200,000 | 0 | $21.78M | $24.42M | 1.72% | +$2.64M |
| Zenas BioPharma, Inc.(ZBIO) | 2,214,967 | 2,250,000 | +35,033 | $17.50M | $21.80M | 1.54% | +$4.30M |
| Enliven Therapeutics Inc | 0 | 1,084,432 | +1,084,432 | $0 | $21.75M | 1.54% | +$21.75M |
| Apogee Therapeutics Inc | 0 | 449,392 | +449,392 | $0 | $19.52M | 1.38% | +$19.52M |
| CeriBell, Inc.(CBLL) | 880,000 | 900,000 | +20,000 | $16.90M | $16.86M | 1.19% | -$47.8K |
| Valneva SEADS(VALN) | 0 | 2,375,000 | +2,375,000 | $0 | $13.47M | 0.95% | +$13.47M |
| 4d Molecular Therapeutics In | 1,950,000 | 2,000,000 | +50,000 | $6.30M | $7.42M | 0.52% | +$1.12M |
| Io Biotech Inc | 3,354,449 | 3,354,449 | 0 | $3.66M | $4.66M | 0.33% | +$1.01M |
| LanzaTech Global, Inc.(LNZA) | 15,814,845 | 15,814,845 | 0 | $3.83M | $4.29M | 0.30% | +$460.2K |
| Marqeta, Inc.CL A(MQ) | 441,558 | 441,558 | 0 | $1.82M | $2.57M | 0.18% | +$755.1K |
| AbCellera Biologics Inc.(ABCL) | 1,126,915 | 652,529 | -474,386 | $2.51M | $2.24M | 0.16% | -$274.8K |
| Damora Therapeutics, Inc.(DMRA) | 99,913 | 99,913 | 0 | $309.7K | $340.7K | 0.02% | +$31.0K |
| Amicus Therapeutics Inc COM | 2,750,000 | 0 | -2,750,000 | $22.44M | $0 | — | -$22.44M |
| Kyverna Therapeutics, Inc.(KYTX) | 1,850,000 | 0 | -1,850,000 | $3.57M | $0 | — | -$3.57M |
| Lexeo Therapeutics, Inc.(LXEO) | 1,122,581 | 0 | -1,122,581 | $3.90M | $0 | — | -$3.90M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 1,100,000 | 0 | -1,100,000 | $7.34M | $0 | — | -$7.34M |
| Verve Therapeutics Inc | 3,000,000 | 0 | -3,000,000 | $13.71M | $0 | — | -$13.71M |